Akili is a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies. The company's approach leverages technologies designed to directly target the brain and establishes a new category of medicine validated through clinical trials like a drug or medical device but experienced like entertainment. Akili's platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs.